Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacy Risk Management Wish-List: “Opt-In” Feature, “Core Protocols”

Executive Summary

Limited distribution programs for pharmaceuticals should include an "opt-in" feature to allow participation of any qualified pharmacy, the American Pharmaceutical Association told FDA during a May 22 hearing on risk management

You may also be interested in...



“Risk Management” May Be Too Risky For Pharmacy, NACDS Tells FDA

The participation of retail pharmacy in FDA-approved risk management programs may depend on "risk management" of a different kind: whether retailers feel sufficiently shielded from any added liability under novel regulatory schemes

“Risk Management” May Be Too Risky For Pharmacy, NACDS Tells FDA

The participation of retail pharmacy in FDA-approved risk management programs may depend on "risk management" of a different kind: whether retailers feel sufficiently shielded from any added liability under novel regulatory schemes

FDA Adverse Event Rating Scale Could Follow NCI Model, Consultant Says

The National Cancer Institute Common Toxicity Criteria could be a model for a standardized adverse event severity scale, International Pharmaceutical Consultants President Herbert Swarz, MD, suggested during a May 22 FDA hearing on risk management

Related Content

UsernamePublicRestriction

Register

OM010563

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel